Business
CareDx Enhances Leadership Team with Key Appointments
CareDx Builds for the Future by Investing in Talent SOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading
About this update from Caredx, Inc.
[{"type":"text","content":"CareDx Builds for the Future by Investing in Talent\nSOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of new senior leaders to create meaningful impact across key growth areas, build for the future, and enhance the patient journey. “As we grow, we will continue to bring incredibly talented senior leaders to build the CareDx Village,” said Reg Seeto, President and Chief Executive Officer, CareDx. ”These recent hires and promotions reinforce our commitment to leadership in multi-modality innovation, places priority on patients first, enhances our integrated digital offerings, helps build new business, and creates a dedicated focus on our Villagers.” CareDx is pleased to share the following new appointments, all designed to bring deep leadership experience to help guide growth and patient connection across all areas of transplantation—from pre-transplant products to post-transplant testing services. Titte R. “Srini” Srinivas, M.D., FAST, Vice President, Digital Development and Clinical Integration, joins CareDx from University Hospitals in Cleveland, where he served as the Chief, Division of Nephrology and Hypertension and Peter B. DeOreo Chair in Nephrology and Dialysis. Srinivas is a transplant nephrologist with extensive clinical experience and publication track record in outcomes research, pharmacology, big data, and predictive analytics spanning the past 20 years.Steven Stone, Ph.D., Vice President, KidneyCare, joins CareDx from Myriad Genetics, where he served as Vice President of Cancer Genomics and developed products for personalized medicine in oncology.Dustin Leach, Pharm.D., Vice President, Customer Experience, joins CareDx from Teva Pharmaceuticals, where he spent almost 15 years, serving most recently as Senior Director, Patient Services – Program Development. In addition, Martyn Edney, has been appointed as Senior Vice President, Head of Human Resources. Martyn joins CareDx from IQVIA, where he was Vice President of Human Resources for the U.S. and Canada. Edney is a highly accomplished HR leader with a strong track record for leading transformati...